Evogene Ltd. (TLV:EVGN)
538.30
+21.60 (4.18%)
Jun 18, 2025, 5:24 PM IDT
Evogene Revenue
Evogene had revenue of $2.44M USD in the quarter ending March 31, 2025, a decrease of -41.67%. This brings the company's revenue in the last twelve months to $6.77M, down -26.38% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.
Revenue (ttm)
$6.77M
Revenue Growth
-26.38%
P/S Ratio
1.79
Revenue / Employee
$57.82K
Employees
117
Market Cap
45.03M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.51M | 2.87M | 50.90% |
Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 61.87B |
Danel (Adir Yeoshua) | 2.81B |
Kamada | 622.70M |
Bait Bakfar | 104.50M |
BrainsWay | 161.81M |
Novolog (Pharm-Up 1966) | 2.07B |
SofWave Medical | 235.09M |
Ilex Medical | 922.08M |
Evogene News
- 8 days ago - Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PRNewsWire
- 4 weeks ago - Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Evogene GAAP EPS of -$0.38, revenue of $2.44M - Seeking Alpha
- 4 weeks ago - Evogene Reports First Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - Evogene Q1 2025 Earnings Preview - Seeking Alpha
- 4 weeks ago - Insights into Evogene's Upcoming Earnings - Benzinga
- 5 weeks ago - Evogene Schedules First Quarter 2025 Financial Results Release - PRNewsWire
- 2 months ago - ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - PRNewsWire